LAUREN GOODWIN: Open Payments
NPI 1790426526 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,999 in 72 payments from 21 companies in 2025. Trend: 2023 $982 · 2024 $1,010 · 2025 $2,999
Food & beverage: $1,685Travel & lodging: $1,234Education: $80
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 11 | $1,566 |
| AstraZeneca Pharmaceuticals LP | 13 | $266 |
| United Therapeutics Corporation | 4 | $120 |
| Regeneron Healthcare Solutions, Inc. | 2 | $117 |
| GENZYME CORPORATION | 4 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $110 |
| GlaxoSmithKline, LLC. | 6 | $96 |
| Insmed, Inc. | 4 | $74 |
| Viatris Specialty LLC | 4 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $63 |
Products named: INSPIRE, DUPIXENT, GLASSIA, Arikayce, AIRSUPRA, YUPELRI, FASENRA, OFEV.
Industry payments across SC — which companies pay providers there.
